These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33093124)

  • 1. Mitochondrial antiviral signaling protein is crucial for the development of pulmonary fibrosis.
    Kim SH; Lee JY; Yoon CM; Shin HJ; Lee SW; Rosas I; Herzog E; Dela Cruz CS; Kaminski N; Kang MJ
    Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33093124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PINK1 Inhibits Multimeric Aggregation and Signaling of MAVS and MAVS-Dependent Lung Pathology.
    Kim SH; Shin HJ; Yoon CM; Lee SW; Sharma L; Dela Cruz CS; Kang MJ
    Am J Respir Cell Mol Biol; 2021 May; 64(5):592-603. PubMed ID: 33577398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoid signalling/cannabinoid receptor 2 is involved in icariin-mediated protective effects against bleomycin-induced pulmonary fibrosis.
    Du W; Zhang T; Yang F; Gul A; Tang Z; Zhang H; Jiang S; Wang S; Dong J
    Phytomedicine; 2022 Aug; 103():154187. PubMed ID: 35667261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects.
    Overed-Sayer C; Miranda E; Dunmore R; Liarte Marin E; Beloki L; Rassl D; Parfrey H; Carruthers A; Chahboub A; Koch S; Güler-Gane G; Kuziora M; Lewis A; Murray L; May R; Clarke D
    Thorax; 2020 Sep; 75(9):754-763. PubMed ID: 32709610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis.
    Espindola MS; Habiel DM; Narayanan R; Jones I; Coelho AL; Murray LA; Jiang D; Noble PW; Hogaboam CM
    Am J Respir Crit Care Med; 2018 Jun; 197(11):1443-1456. PubMed ID: 29634284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleomycin Induces Drug Efflux in Lungs. A Pitfall for Pharmacological Studies of Pulmonary Fibrosis.
    Park JK; Coffey NJ; Bodine SP; Zawatsky CN; Jay L; Gahl WA; Kunos G; Gochuico BR; Malicdan MCV; Cinar R
    Am J Respir Cell Mol Biol; 2020 Feb; 62(2):178-190. PubMed ID: 31419911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological and molecular analysis of idiopathic pulmonary fibrosis lungs from patients treated with pirfenidone or nintedanib.
    Zhang Y; Jones KD; Achtar-Zadeh N; Green G; Kukreja J; Xu B; Wolters PJ
    Histopathology; 2019 Jan; 74(2):341-349. PubMed ID: 30152895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of pirfenidone in a sheep model of pulmonary fibrosis.
    Dewage SNV; Organ L; Koumoundouros E; Derseh HB; Perera KUE; Samuel CS; Stent AW; Snibson KJ
    Exp Lung Res; 2019; 45(9-10):310-322. PubMed ID: 31762329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-fibrotic effect of inhibition of TGFβ-ALK5 signalling in experimental pulmonary fibrosis in mice is attenuated in the presence of concurrent γ-herpesvirus infection.
    Smoktunowicz N; Alexander RE; Franklin L; Williams AE; Holman B; Mercer PF; Jarai G; Scotton CJ; Chambers RC
    Dis Model Mech; 2015 Sep; 8(9):1129-39. PubMed ID: 26138704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients.
    Bondue B; Castiaux A; Van Simaeys G; Mathey C; Sherer F; Egrise D; Lacroix S; Huaux F; Doumont G; Goldman S
    Respir Res; 2019 Jan; 20(1):10. PubMed ID: 30646908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
    Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
    Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia Inducible Factor 1A Supports a Pro-Fibrotic Phenotype Loop in Idiopathic Pulmonary Fibrosis.
    Epstein Shochet G; Bardenstein-Wald B; McElroy M; Kukuy A; Surber M; Edelstein E; Pertzov B; Kramer MR; Shitrit D
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercetin Enhances Ligand-induced Apoptosis in Senescent Idiopathic Pulmonary Fibrosis Fibroblasts and Reduces Lung Fibrosis In Vivo.
    Hohmann MS; Habiel DM; Coelho AL; Verri WA; Hogaboam CM
    Am J Respir Cell Mol Biol; 2019 Jan; 60(1):28-40. PubMed ID: 30109946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate Immune Nod1/RIP2 Signaling Is Essential for Cardiac Hypertrophy but Requires Mitochondrial Antiviral Signaling Protein for Signal Transductions and Energy Balance.
    Lin HB; Naito K; Oh Y; Farber G; Kanaan G; Valaperti A; Dawood F; Zhang L; Li GH; Smyth D; Moon M; Liu Y; Liang W; Rotstein B; Philpott DJ; Kim KH; Harper ME; Liu PP
    Circulation; 2020 Dec; 142(23):2240-2258. PubMed ID: 33070627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis.
    Bauer Y; Tedrow J; de Bernard S; Birker-Robaczewska M; Gibson KF; Guardela BJ; Hess P; Klenk A; Lindell KO; Poirey S; Renault B; Rey M; Weber E; Nayler O; Kaminski N
    Am J Respir Cell Mol Biol; 2015 Feb; 52(2):217-31. PubMed ID: 25029475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of phospholipase D in bleomycin-induced mitochondrial reactive oxygen species generation, mitochondrial DNA damage, and pulmonary fibrosis.
    Suryadevara V; Huang L; Kim SJ; Cheresh P; Shaaya M; Bandela M; Fu P; Feghali-Bostwick C; Di Paolo G; Kamp DW; Natarajan V
    Am J Physiol Lung Cell Mol Physiol; 2019 Aug; 317(2):L175-L187. PubMed ID: 31090437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role for iron accumulation in the pathogenesis of fibrotic lung disease.
    Ali MK; Kim RY; Brown AC; Donovan C; Vanka KS; Mayall JR; Liu G; Pillar AL; Jones-Freeman B; Xenaki D; Borghuis T; Karim R; Pinkerton JW; Aryal R; Heidari M; Martin KL; Burgess JK; Oliver BG; Trinder D; Johnstone DM; Milward EA; Hansbro PM; Horvat JC
    J Pathol; 2020 May; 251(1):49-62. PubMed ID: 32083318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis.
    Lehmann M; Buhl L; Alsafadi HN; Klee S; Hermann S; Mutze K; Ota C; Lindner M; Behr J; Hilgendorff A; Wagner DE; Königshoff M
    Respir Res; 2018 Sep; 19(1):175. PubMed ID: 30219058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schisandra Inhibit Bleomycin-Induced Idiopathic Pulmonary Fibrosis in Rats via Suppressing M2 Macrophage Polarization.
    Guo Z; Li S; Zhang N; Kang Q; Zhai H
    Biomed Res Int; 2020; 2020():5137349. PubMed ID: 32884941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nintedanib Reduces Neutrophil Chemotaxis via Activating GRK2 in Bleomycin-Induced Pulmonary Fibrosis.
    Chen WC; Chen NJ; Chen HP; Yu WK; Su VY; Chen H; Wu HH; Yang KY
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.